Back
Top 0.8%
22.5%
Top 61%
9.1%
#1
7.9%
#1
6.5%
Top 0.8%
6.0%
Top 0.7%
5.1%
Top 1%
5.1%
Top 0.5%
3.9%
Top 73%
2.8%
Top 0.6%
2.8%
Top 0.7%
2.0%
Top 0.5%
2.0%
Top 54%
1.6%
Top 28%
1.6%
Top 7%
1.6%
Top 3%
1.6%
Top 3%
1.4%
Top 1.0%
1.0%
Top 2%
1.0%
Top 16%
1.0%
Genistein effect on cognition in early Alzheimer's disease patients. The GENIAL clinical trial
2022-06-02
geriatric medicine
Title + abstract only
View on medRxiv
Show abstract
BackgroundDelaying the transition from minimal cognitive impairment to Alzheimers dementia is a major concern in Alzheimers disease (AD) therapeutics. Pathological signs of AD occur years before the onset of clinical dementia. Thus, long-term therapeutic approaches, with safe, minimally invasive, and yet effective substances are recommended. There is a need to develop new drugs to delay Alzheimers dementia. We have taken a nutritional supplement approach with genistein, a chemically defined pol...
Predicted journal destinations
1
Alzheimer's & Dementia
84 training papers
2
PLOS ONE
1737 training papers
3
GeroScience
22 training papers
4
Journal of Alzheimer’s Disease
23 training papers
5
Alzheimer's Research & Therapy
31 training papers
6
Age and Ageing
27 training papers
7
Journal of Alzheimer's Disease
31 training papers
8
The Journals of Gerontology: Series A
19 training papers
9
Scientific Reports
701 training papers
10
BMC Geriatrics
15 training papers
11
Aging Cell
21 training papers
12
The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
15 training papers
13
BMJ Open
553 training papers
14
eLife
262 training papers
15
Translational Psychiatry
94 training papers
16
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
28 training papers
17
Neurobiology of Aging
29 training papers
18
Aging
18 training papers
19
Frontiers in Aging Neuroscience
22 training papers
20
Proceedings of the National Academy of Sciences
100 training papers